About Nark Pharmaceuticals
Nark Pharmaceuticals is a Healthcare company. Manufacturing and supplying pharmaceutical medicines in various therapeutic segments. Its Indian entity Nark Pharmaceuticals Private Limited reported revenue of ₹2.64 Cr. Nark Pharmaceuticals offers products and services including Medicines and Supply Chain Services. Its focus areas include Pharmaceuticals, Supply Chain Management, Distribution Networks and Drug Manufacturing.
Company details
Nark Pharmaceuticals is identified as a leading Indian pharmaceutical company that focuses on the availability of high-quality, effective, and affordable medicines for a broad range of illnesses, including chronic and acute treatments in segments like cardiology and neurology. Global standards of quality in drug manufacturing are upheld, alongside the development of an effective supply chain network. Digitization is utilized to enhance business operations, while a trained marketing team is driven to improve patients lives. Commitment is shown to promoting womens participation in the workplace, with over a decade of experience aimed at making a positive difference for patients, customers, and communities.
- SectorsHealthcare
- Email••••••••
- Website narkpharmaceuticals.com
- Legal Name Nark Pharmaceuticals Pvt. Ltd
- Date of Incorporation 08 Dec, 2010
- Jurisdiction Ernakulam, Kerala, India
- Indian entity revenue₹2.64 Cr
FY 2025 · +3% YoY
- Indian entity net profit₹4.9 Lakh
FY 2025 · 2% margin
- Indian entity EBITDA₹8.5 Lakh
FY 2025 · 3% margin
Associated legal entities of Nark Pharmaceuticals
Nark Pharmaceuticals operates through Nark Pharmaceuticals Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Nark Pharmaceuticals Private Limited CIN U51397KL2010PTC027169 | Active | 08 Dec 2010 | Ernakulam, Kerala | ₹2.6 Cr | 2 | 3 | View details |
Products & Services of Nark Pharmaceuticals
Nark Pharmaceuticals offers a comprehensive portfolio of products and services, including Medicines and Supply Chain Services.
High quality effective and affordable medicines are provided for a wide spectrum of chronic and acute treatments
An effective supply chain network is established to meet the demands of a fast-evolving marketplace
Board of directors of Nark Pharmaceuticals Private Limited (Nark Pharmaceuticals)
Nark Pharmaceuticals Private Limited is the primary company behind Nark Pharmaceuticals. The board of Nark Pharmaceuticals Private Limited currently have 3 directors; the longest-serving is Navakumar Narayanan, appointed in 2010. 5 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Navakumar Narayanan DIN 01430410 | Managing Director | 08 Dec 2010 | 15 yrs 10 mo | Nark Pharmaceuticals Private Limited |
| Sudhakara Reddy Dodla DIN 01387896 | Director | 20 Jul 2018 | 8 yrs 3 mo | Nark Pharmaceuticals Private Limited |
| Ritika Anil Kumar DIN 08240538 | Director | 27 Sep 2018 | 8 yrs 1 mo | Nark Pharmaceuticals Private Limited |
Financials of Nark Pharmaceuticals
Figures of Nark Pharmaceuticals Private Limited, the primary company behind Nark Pharmaceuticals, for FY 2025. Revenue was ₹2.64 Cr (+3% year on year). Net profit was ₹4.9 Lakh (2% margin). EBITDA was ₹8.5 Lakh (3% margin). Revenue has grown at a compounded annual rate of -2% over three years and +6% over five years.
- ₹2.64 CrRevenue · FY 2025 · +3% YoY
- ₹4.9 LakhNet profit · 2% margin
- ₹8.5 LakhEBITDA · 3% margin
- ₹53 LakhPaid-up capital
- 2Employees (provident fund records)
- -2%Revenue CAGR, 3 years
- +6%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Nark Pharmaceuticals Private Limited are on its company page.
Detailed financial statements for Nark Pharmaceuticals
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Nark Pharmaceuticals
The primary company behind Nark Pharmaceuticals, Nark Pharmaceuticals Private Limited, reported revenue of ₹2.64 Cr for FY 2025, up 3% year on year.
Nark Pharmaceuticals is identified as a leading Indian pharmaceutical company that focuses on the availability of high-quality, effective, and affordable medicines for a broad range of illnesses, including chronic and acute treatments in segments like cardiology and neurology. Global standards of quality in drug manufacturing are upheld, alongside the development of an effective supply chain network. Digitization is utilized to enhance business operations, while a trained marketing team is driven to improve patients lives. Commitment is shown to promoting womens participation in the workplace, with over a decade of experience aimed at making a positive difference for patients, customers, and communities.
Nark Pharmaceuticals offers Medicines and Supply Chain Services.
Nark Pharmaceuticals operates through Nark Pharmaceuticals Private Limited.
The legal entities of Nark Pharmaceuticals currently have 3 directors, including Ritika Anil Kumar, Navakumar Narayanan, Sudhakara Reddy Dodla.